Therefore, targeting the calpains/calmodulin-calcineurin-NFATc3 axis via the regulation of cytosolic Ca2+ distribution with Ca2+-mobilizing agent like celastrol, is a potential strategy for intervening RA progression. The gene discussed is NFATC3; the disease is rheumatoid arthritis.